Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study to Evaluate ITCA 650 Compared to Sitagliptin as add-on Therapy for the Treatment of Type 2 Diabetes

ClinicalTrials.gov ID: NCT01455870

Public ClinicalTrials.gov record NCT01455870. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 4:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Active Comparator, Double-Blind, Multi-Center Study to Compare the Efficacy, Safety and Tolerability of ITCA 650 to Sitagliptin as Add-on Therapy to Metformin in Patients With Type 2 Diabetes

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Phase 3 study to compare treatment with ITCA 650 to sitagliptin when added to metformin monotherapy in patients with type 2 diabetes.

Study identification

NCT ID
NCT01455870
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Intarcia Therapeutics
Industry
Enrollment
535 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2013
Primary completion
Jun 30, 2015
Completion
Jun 30, 2015
Last update posted
Jun 1, 2016

2013 – 2015

United States locations

U.S. sites
50
U.S. states
23
U.S. cities
47
Facility City State ZIP Site status
Not listed Birmingham Alabama 35235
Not listed Chandler Arizona 85224
Not listed Long Beach California 90807
Not listed Los Angeles California 90017
Not listed San Diego California 92101
Not listed San Mateo California 94401
Not listed Tustin California 92780
Not listed Valley Village California 91607
Not listed Walnut Creek California 94598
Not listed Boca Raton Florida 33432
Not listed Clearwater Florida 33765
Not listed Coral Gables Florida 33134
Not listed Miami Florida 33126
Not listed North Miami Beach Florida 33162
Not listed Pembroke Pines Florida 33026
Not listed Canton Georgia 30114
Not listed Chicago Illinois 60607
Not listed Chicago Illinois 60634
Not listed Avon Indiana 46123
Not listed Franklin Indiana 46131
Not listed Greenfield Indiana 46140
Not listed Muncie Indiana 47304
Not listed Valparaiso Indiana 46383
Not listed Wichita Kansas 67205
Not listed Wichita Kansas 67208
Not listed Metairie Louisiana 70006
Not listed Brockton Massachusetts 2301
Not listed Traverse City Michigan 49684
Not listed Troy Michigan 48098
Not listed St Louis Missouri 63110
Not listed Billings Montana 59101
Not listed Lincoln Nebraska 68510
Not listed Las Vegas Nevada 89148
Not listed Brooklyn New York 11218
Not listed Endwell New York 13760
Not listed Morehead City North Carolina 28557
Not listed Winston-Salem North Carolina 27103
Not listed Cincinnati Ohio 45227
Not listed Kettering Ohio 45429
Not listed Norman Oklahoma 73069
Not listed Bend Oregon 97701
Not listed Uniontown Pennsylvania 15401
Not listed Memphis Tennessee 38119
Not listed Corpus Christi Texas 78414
Not listed Dallas Texas 75230
Not listed Dallas Texas 75390
Not listed Houston Texas 77083
Not listed San Antonio Texas 78229
Not listed Sugar Land Texas 77478
Not listed Tomball Texas 77375

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01455870, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 1, 2016 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01455870 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →